Evidence map›Paper›PMID 25518927›Full record

ReviewMolecules and cells2015

Are macrophages in tumors good targets for novel therapeutic approaches?

Samthosh V Alahari, Shengli Dong, Suresh K Alahari

Open access · diamondAbstract readReview
In one paragraph

Review in Molecules and cells, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Monocytes and Macrophages in Cancer: Unsuspected Roles.Advances in experimental medicine and biology · 2020
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Samthosh V AlahariDepartment of Biochemistry and Molecular Biology, LSU School of Medicine, New Orleans, LA 70112, USA.
Shengli DongDepartment of Biochemistry and Molecular Biology, LSU School of Medicine, New Orleans, LA 70112, USA.
Suresh K AlahariDepartment of Biochemistry and Molecular Biology, LSU School of Medicine, New Orleans, LA 70112, USA.
Tulane University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of cancer has been an extensively researched topic over the past few decades. Although great strides have been made in cancer prevention, diagnosis, and treatment, there is still much to be learned about cancer's micro-environmental mechanisms that contribute to cancer formation and aggressiveness. Macrophages, lymphocytes which originate from monocytes, are involved in the inflammatory response and often dispersed to areas of infection to fight harmful antigens and mutated cells in tissues. Macrophages have a plethora of roles including tissue development and repair, immune system functions, and inflammation. We discuss various pathways by which macrophages get activated, various approaches that can regulate the function of macrophages, and how these approaches can be helpful in developing new cancer therapies.

Indexed as

AnimalsAntineoplastic AgentsHumansMacrophage ActivationMacrophagesMolecular Targeted TherapyNeoplasmsTumor MicroenvironmentAntineoplastic Agentsangiogenesiscancerinvasionmacrophagesmicroenvironmentmigration

Identifiers

PMID25518927
PMCPMC4332036
OpenAlexW2056612511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.